HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought
In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th
AACI Told Medicare “Probably” Has Paid For Extra Patient Care Costs Of Research; Members Object To “Two Level System”
New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance
Trending Stories
- As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill









